After Sputnik V, Russian Federation grants approval to 2nd COVID-19 vaccine EpiVacCorona

Russia pandemic

The new coronavirus vaccine comes two months after a similar move for Russia's first vaccine Sputnik V prompted widespread criticism from scientists both at home and overseas.

Talks are taking place between NHS England, the BMA and other groups over who will administer vaccines and who will receive it first, Pulse reported, citing multiple sources. The vaccine named EpiVacCorona comes after Russian Federation recently granted similar approval to its first COVID-19 vaccine named Sputnik V. Notably, Sputnik V is also the first vaccine candidate in the world to attain regulatory approval.

President Vladimir Putin announced on Wednesday that Russian Federation has registered a second coronavirus vaccine, with a third one in the pipeline, the TASS news agency reported.

"Novosibirsk's Vektor [State Virology and Biotechnology Center] has registered the second Russian coronavirus vaccine today", Putin said via televised video conference.

In August, Russia was the first country to announce the registration of a Covid-19 vaccine, which has since been taken by thousands of Muscovites, and is now mid-way through its final trial phase. The president added that the priority was to supply the Russian market with the vaccines.

The two-shot vaccine, "EpiVacCorona", was tested among 100 volunteers in early-stage, placebo-controlled human trials, which lasted more than two months and were completed two weeks ago.


Antibody levels were also lower in those aged 60-80 years compared with those aged 18-59, they said.

The EpiVacCorona is a peptide synthetic vaccine based on a recombinant virus.

Scientists have yet to publish the results of the study.

The trial was not created to assess efficacy of the vaccine, so it is not possible to say whether the antibody responses induced by the vaccine, called BBIBP-CorV, are sufficient to protect from SARS-CoV-2 infection, according to the researchers.

According to Deputy Prime Minister Tatyana Golikova, 60,000 doses of the vaccine are due to be released soon. She also said that 40,000 volunteers will participate in a third-phase clinical trial, including people over 65 years-old.

Related:

Comments

Latest news

Samsung Galaxy S20 FE available for sale today, discounts of Rs 4000
The limited-period sale offer includes a discount of INR 4,000 when the purchase is made using HDFC Bank credit or debit card. The customers can buy the online from Samsung.com, Amazon and Flipkart and offline on all the authorized retail stores.

Georgia-Alabama line gets jolt from Saban's COVID diagnosis
Alabama said earlier that Saban was evaluated by team doctor Jimmy Robinson Thursday "and is doing fine". I'm just right down the street.

Mercedes boss Wolff laughs off ‘best car’ Hamilton critics
The greatest I believe there has been is Juan Manuel Fangio, followed by Jim Clark. So you see a bit more of the skills and the auto control.

Police finally identify man who killed nine-year-old Christine Jessop
Her neighbor, Guy Paul Morin, ended up being charged in 1984 before being wrongly convicted and sentenced to life in prison. Morin received $1.25 million from the Ontario government and a public apology after he was acquitted of Jessop's murder.

Online Sports Betting Market Growth
Benefits With the market high, sports betting is an activity that receives a high level of support from online betting companies. More betters are opting to forego the long lines at the cashier's counter and the unavailability of their favorite machines.

Other news